Emerging Pharmaceutical Market in China - Forecast to Become The World’s Third-Largest Pharmaceutical Market By 2013





Summary 

GBI Research’s new report, “Emerging Pharmaceutical Market in China - Forecast to Become The World’s Third-Largest Pharmaceutical Market By 2013”, provides in-depth analysis of trends, issues and challenges in this industry. The report analyzes the effective strategies that shape the industry dynamics. Further, the report provides competitive benchmarking for the leading companies and analyzes the M&A and strategic partnerships that shape the Chinese pharmaceutical market. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GBI Research’s team of industry experts. 

Scope 

The scope of this report includes -
- Overall pharma, biotech and outsourcing market structure.
- Market characterization, including market size
- CMO & CRO market size and growth
- Key drivers and barriers that have a significant impact on the market.
- Competitive benchmarking of leading companies.
- Key M&A activities and strategic partnership deals that have taken place in 2009
 

Reasons to buy 

The report will enhance your decision making capability. It will allow you to -
- Align your product portfolio to the markets with high growth potential.
- Develop market-entry and market expansion strategies by identifying the leading therapeutic segments poised for strong growth.
- Device a more tailored country strategy through the understanding of key drivers and barriers of the country’s pharmaceutical market.
- Develop key strategic initiatives by understanding the key focus areas of leading companies.
- Accelerate and strengthen your market position by identifying key companies for mergers, acquisitions and strategic partnerships.
 
 

  

1 Table of Contents
1 Table of Contents 3
1.1 List of Tables 5
1.2 List of Figures 6
2 Emerging Pharmaceutical Market: China – Introduction 7
2.1 GBI Research Report Guidance 10
3 Emerging Pharmaceutical Market: China – Macroeconomic Environment 11
3.1 Demographic Analysis 11
3.2 PEST Analysis 13
3.2.1 Political Factors 13
3.2.2 Economic Factors 14
3.2.3 Social Factors 14
3.2.4 Technological Factors 14
4 Emerging Pharmaceutical Market: China – Industry Performance 15
4.1 China (Past, Present and Future Scenario) 15
4.1.1 Macroeconomic Indicators 15
4.1.2 Population Profile 19
4.1.3 Environmental Burden of Disease 19
4.1.4 Healthcare Spending and Financing 26
4.1.5 Imports and Exports 27
4.1.6 Branded and Generic Drugs 29
4.1.7 Healthcare Infrastructure 29
5 Emerging Pharmaceutical Market: China – Pharma and Biotech Industry 32
5.1 Pharmaceutical Market Size and Growth in China 32
5.2 Biotech Market Size and Growth in China 33
5.3 Major Regulatory Bodies in China 34
5.3.1 SFDA (State Food and Drug Administration) 34
5.3.2 CDE (Center for Drug Evaluation) 34
5.3.3 NDRC (National Development and Reform Commission) 35
5.3.4 NICPBP (National Institute for the Control of Pharmaceutical and Biological Products) 35
5.4 Key Pharmaceutical Regulations in China 36
5.4.1 Ministry of Health 36
5.4.2 The National Development and Reform Commission 37
5.4.3 Chinese Center for Disease Control and Prevention (China CDC) 37
5.4.4 The Ministry of Finance 37
5.4.5 Ministry of Labor and Social Security (MoLSS) 37
5.5 Pricing and Reimbursement in China 38
5.5.1 Pricing of Pharmaceutical Drugs in China 38
5.5.2 Reimbursements of Pharmaceutical Drugs in China 39
5.6 Intellectual Property Rights in China 39
5.6.1 Patent Law 40
5.6.2 Trademark Law 40
5.6.3 Anti-Unfair Competition Law 41
5.6.4 Regulations on Customs Protection of Intellectual Property Rights 42
5.7 Key Marketing and Distribution Channels in China 42
5.7.1 Current Distribution Situation in China 43
5.7.2 Modern Pharmaceutical Logistics in China 43
5.7.3 Foreign-Invested Distributors in China 43
5.8 Key Distributors – Foreign 44
5.8.1 AstraZeneca China 44
5.8.2 Bayer Schering Pharma China 44
5.8.3 Shanghai Roche Pharmaceutical Corp. 44
5.8.4 Xian-Janssen (Johnson & Johnson) 44
5.8.5 Sanofi-Aventis 44
5.9 Key Distributors – Domestic 45
5.9.1 Sinopharm Group Co. Ltd. 45
5.9.2 Shanghai Pharmaceutical Co. Ltd. 45
5.9.3 Jointown Group Corp 46
5.9.4 Harbin Pharmaceutical Group Corp. 46
5.9.5 Taiji Group Corp. 46
5.10 M&A Deals 47
5.10.1 Top 10 Deals Summary Between 2009 and 2011 47
5.11 Licensing Agreements 49
5.11.1 Top 10 Licensing Deals Summary Between 2009 and 2011 49
5.12 Market Drivers and Restraints 51
5.12.1 Market Drivers 52
5.12.2 Market Restraints 52
6 Emerging Pharmaceutical Market: China – Service Industries – Contract Research and Manufacturing Services (CRAMS) 54
6.1 Introduction 54
6.2 CMO Market Size and Growth in China 54
6.2.1 Key CMO Companies – Domestic 55
6.2.2 Key CMO Companies – Foreign 57
6.3 CMO Market Drivers and Restraints 62
6.3.1 CMO Market Drivers 62
6.3.2 CMO Market Restrains 63
6.4 CRO Market Size and Growth in China 63
6.4.1 Key CRO Companies – Domestic 65
6.4.2 Key CRO Companies – Foreign 70
6.4.3 Top 10 Deals Summary Between 2009 to 2011 75
6.4.4 Top 10 Licensing Summary Between 2009 to 2011 76
6.5 CRO Market Drivers and Restrains 78
6.5.1 CRO Market Drivers 79
6.5.2 CRO Market Restraints 79
7 Emerging Pharmaceutical Market: China – Service Industries –Healthcare IT 80
7.1 Healthcare IT Market Size and Growth in China 80
8 Emerging Pharmaceutical Market: China – Appendix 81
8.1 Market Definitions 81
8.2 Abbreviations 81
8.3 Research Methodology 82
8.3.1 Coverage 82
8.3.2 Secondary Research 83
8.3.3 Primary Research 83
8.3.4 Expert Panel Validation 83
8.4 Contact Us 84
8.5 Disclaimer 84
8.6 Sources 841.1 List of Tables
Table 1: Emerging Pharmaceutical Market, China, Major Infections in China (million), 2009 19
Table 2: Emerging Pharmaceutical Market, China, Top 10 Leading Causes of Death in Urban and Rural China, 2009 20
Table 3: Emerging Pharmaceutical Market – China, Population Forecast for HIV (‘000), 2010-2015 21
Table 4: Emerging Pharmaceutical Market, China, Population Forecast for CVD (million), 2010-2015 22
Table 5: Emerging Pharmaceutical Market, China, Population Forecast for Diabetes (million), 2010–2015 23
Table 6: Emerging Pharmaceutical Market, China, Population Forecast for Cancer (million), 2010-2015 24
Table 7: Emerging Pharmaceutical Market, China, Population Forecast for COPD (million), 2010–2015 25
Table 8: Emerging Pharmaceutical Market, China, Healthcare Infrastructure, 2009 291.2 List of Figures
Figure 1: Emerging Pharmaceutical Market, China, Forecast Rank of China, 2009–2013 7
Figure 2: Emerging Pharmaceutical Market, China, Revenue ($bn), 2009–2014 8
Figure 3: Emerging Pharmaceutical Market, Top 10 Populations by Country (million), 2011 11
Figure 4: Emerging Pharmaceutical Market, China, Population by Gender (%), 2011 12
Figure 5: Emerging Pharmaceutical Market, China, PEST Analysis, 2011 13
Figure 6: Emerging Pharmaceutical Market, China, Population Growth (million), 2009–2050 16
Figure 7: Emerging Pharmaceutical Market, China, Middle Class Population (million), 1995–2020 17
Figure 8: Emerging Pharmaceutical Market, China, Number of Citizens Earning More Than $25,000 Annually (million), 2005-2015 17
Figure 9: Emerging Pharmaceutical Market, China, Population (‘000), 2010-2050 18
Figure 10: Emerging Pharmaceutical Market, China, Population Forecast for HIV (‘000), 2010–2015 21
Figure 11: Emerging Pharmaceutical Market, China, Population Forecast for CVD (million), 2010–2015 22
Figure 12: Emerging Pharmaceutical Market, China, Population Forecast for Diabetes (million), 2010–2015 23
Figure 13: Emerging Pharmaceutical Market, China, Population Forecast for Cancer (million), 2010–2015 24
Figure 14: Emerging Pharmaceutical Market, China, Population Forecast for COPD (million), 2010–2015 25
Figure 15: Emerging Pharmaceutical Market, China, Import and Export Values ($m), 2009 27
Figure 16: Emerging Pharmaceutical Market, China, Pharmaceutical Market Revenue ($bn), 2000-2010 32
Figure 17: Emerging Pharmaceutical Market, China, Biotech Market Revenue ($m), 1989–2005 33
Figure 18: Emerging Pharmaceutical Market, China, Market Drivers & Restraints 51
Figure 19: Emerging Pharmaceutical Market, China, Lonza, Company Profile, 2011 57
Figure 20: Emerging Pharmaceutical Market, China, Boehringer Ingelheim, Company Profile, 2011 58
Figure 21: Emerging Pharmaceutical Market, China, DSM, Company Profile, 2011 59
Figure 22: Emerging Pharmaceutical Market, China, Evonik, Company Profile, 2011 60
Figure 23: Emerging Pharmaceutical Market, China, Pfizer Inc, Company Profile, 2011 61
Figure 24: Emerging Pharmaceutical Market, China, CMO Market Drivers & Restraints 62
Figure 25: Emerging Pharmaceutical Market, China, Wuxi Pharma Tech., Company Profile, 2011 65
Figure 26: Emerging Pharmaceutical Market, China, Shanghai ChemPartner Co. Ltd, Company Profile, 2011 66
Figure 27: Emerging Pharmaceutical Market, China, Shanghai Genomics, Company Profile, 2011 67
Figure 28: Emerging Pharmaceutical Market, China, Zensun (Shanghai) Sci & Tech Co., Ltd, Company Profile, 2011 68
Figure 29: Emerging Pharmaceutical Market, China, Shanghai LeadDiscovery Pharma, Company Profile, 2011 69
Figure 30: Emerging Pharmaceutical Market, China, Quintiles Transnational Corp, Company Profile, 2011 70
Figure 31: Emerging Pharmaceutical Market, China, Covance, Company Profile, 2011 71
Figure 32: Emerging Pharmaceutical Market, China, PPD, Company Profile, 2011 72
Figure 33: Emerging Pharmaceutical Market, China, Charles River Laboratories, Company Profile, 2011 73
Figure 34: Emerging Pharmaceutical Market, China, Parexel, Company Profile, 2011 74
Figure 35: Emerging Pharmaceutical Market – China, CRO Market Drivers & Restraints 78

Companies mentioned
Sinopharm Group Co. Ltd.
Shanghai Pharmaceutical Co. Ltd.
Jointown Group Corp
Harbin Pharmaceutical Group Corp.
Taiji Group Corp.